| BloodinMyEye vs Jin | 63–34 | 64.95% |
| BloodinMyEye vs Reina | 43–36 | 54.43% |
| BloodinMyEye vs King | 36–38 | 48.65% |
| BloodinMyEye vs Kazuya | 50–22 | 69.44% |
| BloodinMyEye vs Steve | 33–35 | 48.53% |
| BloodinMyEye vs Hwoarang | 27–35 | 43.55% |
| BloodinMyEye vs Bryan | 31–28 | 52.54% |
| BloodinMyEye vs Paul | 23–28 | 45.10% |
| BloodinMyEye vs Law | 30–21 | 58.82% |
| BloodinMyEye vs Xiaoyu | 30–19 | 61.22% |
| BloodinMyEye vs Feng | 28–21 | 57.14% |
| BloodinMyEye vs Lili | 21–26 | 44.68% |
| BloodinMyEye vs Dragunov | 21–23 | 47.73% |
| BloodinMyEye vs Asuka | 26–15 | 63.41% |
| BloodinMyEye vs Lee | 20–15 | 57.14% |
| BloodinMyEye vs Azucena | 16–19 | 45.71% |
| BloodinMyEye vs Jun | 12–22 | 35.29% |
| BloodinMyEye vs Eddy | 18–12 | 60.00% |
| BloodinMyEye vs Lars | 11–16 | 40.74% |
| BloodinMyEye vs Nina | 10–17 | 37.04% |
| BloodinMyEye vs Yoshimitsu | 8–17 | 32.00% |
| BloodinMyEye vs Leo | 14–11 | 56.00% |
| BloodinMyEye vs Raven | 9–15 | 37.50% |
| BloodinMyEye vs Alisa | 9–13 | 40.91% |
| BloodinMyEye vs Jack-8 | 8–11 | 42.11% |
| BloodinMyEye vs Shaheen | 12–6 | 66.67% |
| BloodinMyEye vs Victor | 9–9 | 50.00% |
| BloodinMyEye vs Leroy | 7–9 | 43.75% |
| BloodinMyEye vs Devil Jin | 6–7 | 46.15% |
| BloodinMyEye vs Zafina | 4–7 | 36.36% |
| BloodinMyEye vs Claudio | 5–5 | 50.00% |
| BloodinMyEye vs Kuma | 0–3 | 0.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.